Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Where EGF receptors transmit their signals.

Lill NL, Sever NI.

Sci Signal. 2012 Sep 25;5(243):pe41.

2.

A novel biotinylated lipid raft reporter for electron microscopic imaging of plasma membrane microdomains.

Krager KJ, Sarkar M, Twait EC, Lill NL, Koland JG.

J Lipid Res. 2012 Oct;53(10):2214-25. doi: 10.1194/jlr.D026468. Epub 2012 Jul 20.

3.

Cbl controls EGFR fate by regulating early endosome fusion.

Visser Smit GD, Place TL, Cole SL, Clausen KA, Vemuganti S, Zhang G, Koland JG, Lill NL.

Sci Signal. 2009 Dec 22;2(102):ra86. doi: 10.1126/scisignal.2000217.

4.

Nedd4 controls animal growth by regulating IGF-1 signaling.

Cao XR, Lill NL, Boase N, Shi PP, Croucher DR, Shan H, Qu J, Sweezer EM, Place T, Kirby PA, Daly RJ, Kumar S, Yang B.

Sci Signal. 2008 Sep 23;1(38):ra5. doi: 10.1126/scisignal.1160940.

5.
6.

Epidermal growth factor receptor fate is controlled by Hrs tyrosine phosphorylation sites that regulate Hrs degradation.

Stern KA, Visser Smit GD, Place TL, Winistorfer S, Piper RC, Lill NL.

Mol Cell Biol. 2007 Feb;27(3):888-98. Epub 2006 Nov 13.

7.

The Cbl RING finger C-terminal flank controls epidermal growth factor receptor fate downstream of receptor ubiquitination.

Visser GD, Lill NL.

Exp Cell Res. 2005 Dec 10;311(2):281-93. Epub 2005 Oct 24.

PMID:
16246327
8.

The Cbl proto-oncogene product negatively regulates the Src-family tyrosine kinase Fyn by enhancing its degradation.

Andoniou CE, Lill NL, Thien CB, Lupher ML Jr, Ota S, Bowtell DD, Scaife RM, Langdon WY, Band H.

Mol Cell Biol. 2000 Feb;20(3):851-67.

9.

The evolutionarily conserved N-terminal region of Cbl is sufficient to enhance down-regulation of the epidermal growth factor receptor.

Lill NL, Douillard P, Awwad RA, Ota S, Lupher ML Jr, Miyake S, Meissner-Lula N, Hsu VW, Band H.

J Biol Chem. 2000 Jan 7;275(1):367-77.

10.
11.

Cbl-mediated negative regulation of the Syk tyrosine kinase. A critical role for Cbl phosphotyrosine-binding domain binding to Syk phosphotyrosine 323.

Lupher ML Jr, Rao N, Lill NL, Andoniou CE, Miyake S, Clark EA, Druker B, Band H.

J Biol Chem. 1998 Dec 25;273(52):35273-81.

12.

Binding and modulation of p53 by p300/CBP coactivators.

Lill NL, Grossman SR, Ginsberg D, DeCaprio J, Livingston DM.

Nature. 1997 Jun 19;387(6635):823-7.

PMID:
9194565
13.

The Cbl protooncogene product: from an enigmatic oncogene to center stage of signal transduction.

Miyake S, Lupher ML Jr, Andoniou CE, Lill NL, Ota S, Douillard P, Rao N, Band H.

Crit Rev Oncog. 1997;8(2-3):189-218. Review.

PMID:
9570294
14.

p300 family members associate with the carboxyl terminus of simian virus 40 large tumor antigen.

Lill NL, Tevethia MJ, Eckner R, Livingston DM, Modjtahedi N.

J Virol. 1997 Jan;71(1):129-37.

15.

Association of p300 and CBP with simian virus 40 large T antigen.

Eckner R, Ludlow JW, Lill NL, Oldread E, Arany Z, Modjtahedi N, DeCaprio JA, Livingston DM, Morgan JA.

Mol Cell Biol. 1996 Jul;16(7):3454-64.

17.

Characterization of an HPV type 11 isolate propagated in human foreskin implants in nude mice.

Dollard SC, Chow LT, Kreider JW, Broker TR, Lill NL, Howett MK.

Virology. 1989 Jul;171(1):294-7.

PMID:
2545034
18.

In vivo transformation of human skin with human papillomavirus type 11 from condylomata acuminata.

Kreider JW, Howett MK, Lill NL, Bartlett GL, Zaino RJ, Sedlacek TV, Mortel R.

J Virol. 1986 Aug;59(2):369-76.

Supplemental Content

Support Center